premeeting intelligence for:

Joaquin Duato

,

Chief Executive Officer at Johnson & Johnson

Contact Intelligence
Account Intelligence

Joaquin Duato

Chief Executive Officer at Johnson & Johnson
Decisive
Assertive
Fast-Paced
Determined
Persuasive
Ambitious
Dynamic
Visionary
Spontaneous
Pioneering
Adventurous
Casual
Enthusiastic
Personable
Adaptable
Optimistic
Inventive
Approachable
Warm
Hospitable
Intuitive
Friendly
Accommodating
Diplomatic
Composed
Thoughtful
Agreeable
Careful
Modest
Consistent
Conscientious
Perceptive
Calm
Diligent
Meticulous
Collected
Accurate
Rational
Reserved
Strong-willed
Skeptical
Straightforward
Efficient
Candid
Steadfast
Focused
Vigorous
Persistent
Location:
New Brunswick, New Jersey, United States
Education:
Esade - Master of Business Administration (M.B.A.)
Overview:
  • Duato is a dual citizen of Spain and the United States. He is the Chairman and CEO of Johnson & Johnson, an American multinational conglomerate.
  • He is the eighth person to be CEO of Johnson & Johnson since it became a publicly-traded company in 1944.
  • In January 2022, Joaquin Duato became Johnson & Johnson’s new CEO. It’s a role that builds on his 33-year career at the company, working across all business sectors and in multiple countries around the globe.
Quotes

ON COMPANY ORIGINS...

"Proud to be the 8th CEO of Johnson & Johnson in its 135 years of history, and also the first one who is not US born for a company with such a rich global history, a legacy." source

ON INVESTMENT IN CHINA...‍

"China is vitally important to us globally and we remain committed to investing in China, and making a significant contribution to the country's economic growth." source

ON EXTERNAL PARTNERSHIP...

"We have to be externally focused on being able to partner with multiple companies, most of the times smaller companies than us, and being able to add value with our own capabilities, which are more in areas of bringing scale in clinical development/manufacturing and commercialization." source

DISC Type:
Captain (D)
DISC Type:
Driver (Di)
DISC Type:
Initiator (DI)
DISC Type:
Influencer (Id)
DISC Type:
Motivator (I)
DISC Type:
Encourager (Is)
DISC Type:
Harmonizer (IS)
DISC Type:
Counselor (Si)
DISC Type:
Supporter (S)
DISC Type:
Planner (Sc)
DISC Type:
Stabilizer (SC)
DISC Type:
Editor (Cs)
DISC Type:
Analyst (C)
DISC Type:
Skeptic (Cd)
DISC Type:
Questioner
DISC Type:
Architect (Dc)
How to communicate
Focus on their need for control and results, be direct and to the point.
Do
Provide specific details about the product's features and benefits
Highlight how the product will solve their problems and make their life easier
Don't
Beat around the bush or offer vague information
Be too pushy or salesy
When communicating with them, focus on being direct, confident, and results-oriented.
Do
Speak in a fast-paced, confident tone
Focus on the bottom line and how your product can help them achieve their goals
Don't
Use too much jargon or technical language
Waste time on small talk or irrelevant details
Focus on big ideas, big concepts, and fast action over analysis.
Do
Use a direct and assertive tone
Emphasize results and benefits over features
Don't
Use overly flowery language or too many details
Be pushy or aggressive
Communicate with energy and a lively approach. Engage them by communicating clearly and vividly.
Do
Use inspiring language and be enthusiastic
Show them how the product can enhance their social status or reputation
Don't
Be too technical or confusing
Focus solely on features without considering how it can improve their life
Communicate in a friendly, casual manner and highlight the benefits of the product. Avoid criticism or confrontation.
Do
Use a light-hearted approach to build rapport
Highlight how the product can benefit their life or work
Don't
Be overly critical or confrontational
Use overly technical or confusing language
Interact with them in a friendly, agreeable manner with a light-hearted approach. Avoid criticism and confrontation.
Do
Wrap your pitch with positivity and emotional language
Include personalized, warm greetings and sincere sign off
Don't
Use forceful or high-pressure language
Talk too much about past experience without explaining the important insights
Focus on building a personal relationship and finding common ground. Speak positively and offer reassurance about the product.
Do
Engage them in conversation and find out their interests and concerns
Offer personalized recommendations and highlight how the product can meet their needs
Don't
Push too hard or use aggressive sales tactics
Dismiss or minimize their concerns or objections
Provide detailed information and use a friendly, personal tone
Do
Explain how your product can meet their specific needs
Use stories or examples that they can relate to
Don't
Use technical language or jargon
Push for a quick decision without building rapport first
Provide a warm, friendly greeting and use positive, upbeat language. Focus on building a relationship and show acceptance for who they are.
Do
Use friendly, expressive language
Refer to common interests and associations
Don't
Use a serious, businesslike tone
Bring up your flaws before they do
Focus on building a relationship and connecting with them on a personal level.
Do
Use a warm, friendly tone
Ask about their interests and hobbies
Don't
Use overly technical language
Pressure them into making a decision
Be friendly and focus on building a relationship with them. Use a light-hearted approach and avoid criticism or confrontation.
Do
Focus on building a friendly relationship
Validate their opinions and approach with positive language
Don't
Use forceful or high-pressure language
Force an aggressive sales pitch
Use a straightforward and logical approach when communicating with them
Do
Provide data and logical reasoning to support your claims
Use clear and concise language
Don't
Use overly expressive or emotional language
Use lots of anecdotes or storytelling
Use a serious, businesslike tone and focus on details, data, and results.
Do
Focus on their toughest problems.
Send additional data to support your pitch
Don't
Bring up your flaws before they do
Be unrealistically optimistic
Focus on providing logical reasoning and factual information. Be patient and answer their questions with clear and concise responses.
Do
Provide data-driven reasons for your product
Answer their questions with a well-thought-out response
Don't
Use overly expressive language
Speak in an overly casual manner
Focus on concrete data, specifics, and logistics. Avoid fluffy language and hype.
Do
Provide clear data and statistics to support the product
Present a clear, logical argument for why the product is worth investing in
Don't
Spend too much time on abstract concepts or big ideas
Get sidetracked with small details or anecdotes
When communicating with them, focus on being clear, concise, and results-oriented.
Do
Provide clear and concise information about the product and its benefits
Focus on results and practical details
Don't
Use overly descriptive or flowery language
Waste time on social chatter or small talk
Executive priorities
  • Drive innovation and R&D initiatives to develop groundbreaking pharmaceutical solutions.
  • Foster strategic partnerships and collaborations to expand market reach and drive growth.
  • Prioritize regulatory compliance and quality assurance to ensure product safety and efficacy.
  • Champion a culture of diversity, equity, and inclusion across all levels of the organization.
Media
Fierce Pharma

J&J's Joaquin Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings

It didn’t take long for Johnson & Johnson CEO Joaquin Duato to catch up to his predecessor.

Forbes

Pharma CEOs Will Testify Today Over Prescription Drug Prices

Johnson & Johnson CEO Joaquin Duato, Merck CEO Robert Davis, and Bristol Myers Squibb CEO Chris Boerner will testify before the Senate Committee on Health, Education, and Labor.

Bloomberg

The Architect of J&J's Breakup Bets on Tech for the Future of Drugs

Joaquin Duato, who helped mastermind the health giant's breakup, faces the challenge of convincing skeptics on Wall Street that his pursuit of tech-industry luster goes far enough.

Personality traits
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Risk-Tolerant
Risk-Averse
Trusting
Skeptical
Optimistic
Pragmatic
Deliberate
Fast-Paced
Matter-Of-Fact
Expressive
Autonomous
Collaborative
Supporting
Dominant
Build rapport
  • Speak with confident language
  • Ask a bold question early
  • Be concise and to the point
Gather information
  • Learn about his team's current efficiency
  • Ask him urgent questions right off the bat
  • Get through the most important questions up front
Discuss budget
  • Compare your pricing with competitors
  • Give him the bottom-line pricing without going into details
  • Allow some room for him to negotiate
Drive action
  • Explain how taking action will help him make progress
  • Push for a quick decision
  • Focus on the advantages he will gain
Negotiate
  • Challenge both parties to come up with a better solution
  • Use assertive, confident language
  • End the discussion and revisit it later if he is being too firm
Work together
  • Resist the temptation to apologize
  • Make clear what you need from him
  • Give him a deadline for answering

Johnson & Johnson

Johnson & Johnson Innovative Medicine pioneers transformative treatments, driven by patient experiences and rigorous science, championing regulatory frameworks for future-proof innovation.
Industry:
Pharmaceuticals
Headquarters:
New Brunswick, New Jersey, United States
Revenue:
$85.15B
Employees:
152,700

How to negotiate

Keep the discussion casual, but be prepared for candid pushback, at times.
Keep your demo concise and to the point
Keep your demo concise and to the point
Keep your demo concise and to the point
Company Milestones
  • 1886: Johnson & Johnson founded.
  • 1921: Acquires Chicopee Manufacturing Company.
  • 1959: Launches Tylenol.
  • 1982: Introduces Acuvue contact lenses.
  • 2021: 135 years of pioneering healthcare solutions.

Demo your product

Notice how he uses your product and let him have fun trial-and-erroring on his own.
Keep your demo concise and to the point
Keep your demo concise and to the point
Top Products
  • Tylenol: Trusted pain relief medication.
  • Band-Aid: Iconic wound care brand.
  • Acuvue: Leading contact lens brand.
  • Neutrogena: Popular skincare products.
  • Johnson's Baby: Trusted baby care essentials.
Key Executives
Company Stock Performance
Key News
BBC

Johnson & Johnson ordered to pay man $8bn over breast growth

A Philadelphia jury made the award to Nicholas Murray, 26, whose case was one of thousands pending in the state.

October, 2019

Forbes

Johnson & Johnson Is Already Ramping Up Production On Its $1 Billion Coronavirus Vaccine

Now the company’s chief scientist says it will also spend $500 million as part of a $1 billion partnership with the U.S.

March, 2020

AP

Johnson & Johnson to split into 2, aim for faster growth

Johnson & Johnson is peeling off a consumer health business that helped it become the world’s biggest health care products maker.

Nov, 2021

CNN

‘Reassuring’ data suggests Johnson & Johnson vaccine may still have a role to play against Covid-19

The US public and even some health experts may have underestimated the Covid-19 vaccine made by Janssen, a division of Johnson & Johnson, new data shows.

March, 2022

Competitive Landscape
Annual Revenue:
$85.15B
  • J&J's has more than 130,000 employees worldwide.
  • J&J revenue growth 2023 was $85.15B, a 6.46% increase from 2022.
  • J&J: Pharmaceuticals, medical devices, consumer health products.
Annual Revenue:
$58.5B
  • Pfizer has 88,000 employees globally.
  • Revenues growth in 2023 was $58.50B, reflecting 41% decrease from 2022.
  • Pfizer: Diverse pharmaceuticals including COVID-19 vaccine.
Annual Revenue:
$60.1B
  • Merck has over 72,000 employees globally.
  • Revenue growth in 2023 was $60.11B, an increase of 1.4%.
  • Merck: Innovative medicines, vaccines, and animal health products.
Annual Revenue:
$50.3B
  • Sanofi has over 91,000 employees globally.
  • Revenue growth in 2023 was $50.26B, an increase of 5.11%.
  • Sanofi: Global healthcare leader in pharmaceuticals and vaccines.
Want meeting insights?
Our zero-software service prepares you for your most important meetings.
Apply to beta test
View more executives
Richard Banfield
Advisor, author, artist & recovering CEO.
Drew D'Agostino
CEO and Founder of Crystal
See all executives
What is this report?
This pre-meeting report contains insights to help you feel prepared and confident before meetings.

Want help preparing for your next meeting?

Our zero-software service is designed to make you confident
and well-prepared before your most important meetings.
Apply to beta test